Read the full interview:
We are proud to be recognized as one of Switzerland's most promising scale-ups in 2022.
Read moreTopical Wound Treatment with a NO-Releasing PDE5 Inhibitor Formulation Enhances Blood Perfusion and Promotes Healing in Mice.
Read moreThe Board of Directors of Topadur Pharma AG announces that Pascal Brenneisen will leave his position as CEO
Read more